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Studies on the mechanisms involved in thymic atrophy during 
Salmonella enterica serovar Typhimurium infection 
 
T lymphocytes are an essential component of the adaptive immune response and are 
highly versatile in function. Each T cell has a unique T cell receptor that can recognize 
an antigenic peptide in the context of the major histocompatibility complex (MHC) 
encoded molecules, thus offering a high degree of specificity to the immune response. T 
cells play a central role in the development of an effective host immune response and 
the quantitative and qualitative regulation of the T cell response is critical. T cells 
develop in the thymus, an important primary immune organ, where immature 
thymocytes undergo differentiation and maturation. Through the process of thymic 
differentiation, immature cluster of differentiation (CD)4-CD8- thymocytes progress to a 
CD4+CD8+ stage and are subjected to positive and negative selection to give rise to 
MHC restricted, single positive CD4+ or CD8+ naive T cells that emigrate from the 
thymus and populate the peripheral lymphocyte pool.  
 
Thymic atrophy is well known to occur naturally during the process of aging with 
thymocyte depletion and reduced thymic output. Along with age associated changes 
leading to atrophy, the thymus is exquisitely sensitive to starvation and several stresses.  
In addition, thymic atrophy is a characteristic feature during several viral, bacterial and 
parasitic infections. Egress of immature thymocytes, loss of thymic populations due to 
sensitivity to glucocorticoids and cytokine modulation, etc. have been variously 
proposed to be involved in this process. However there is limited understanding on the 
numerous mechanisms involved and the crosstalk between these diverse pathways.   
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In this study, a model for thymic atrophy during acute Salmonella enterica serovar 
Typhimurium (S. typhimurium) infection was developed. S. typhimurium is a Gram 
negative bacterium that resides and grows in intracellular compartments within host 
cells. It causes gastroenteritis in humans but leads to typhoid like disease in mice, 
similar to that caused by S. typhi in humans. Initially, it was established that acute 
infection of C57BL/6 mice with 108 CFU S. typhimurium, via the oral, i.e. the 
physiological, route of infection leads to extensive depletion (8-10 fold) of thymocytes 
in an infection-dependent manner. Infected mice had higher CFU burden in the Peyer’s 
patches, spleen, liver, and mesenteric lymph node (MLN) as compared to the thymus. 
The thymic atrophy was dependent upon the infection caused by live S. typhimurium 
since oral feeding of mice even with higher doses (1010 CFU) of heat-killed bacteria did 
not lead to thymic atrophy. The susceptible populations in the thymus were identified 
by staining for expression of CD4 and CD8 on cell surface using specific monoclonal 
antibodies tagged to fluorophores, e.g. Fluorescein isothiocyanate (FITC) and 
phycoerythrin (PE), respectively. The double labelled samples were analyzed by flow 
cytometry. Interestingly, significant death of CD4+CD8+, the major population of 
thymocytes, but not single positive thymocytes or peripheral lymphocytes (MLN and 
spleen cells), was observed at later stages during infection.  
 
To gain greater understanding of the processes involved, the mechanisms leading to 
thymic atrophy were investigated. To this purpose, small molecule inhibitors and mice 
lacking key molecules important for the immune response were utilized. Also, various 
assays to assess death of thymocytes, including analysis of death markers such as 
Annexin V based detection of membrane flipping and caspase activation were 
performed.  
 
I. The extrinsic death pathway involving Fas/FasL interactions is a major death 
pathway. Therefore, the expression and functional role of the components of the 
pathway in this model of thymocyte death was investigated. It was observed that 
thymocytes from infected mice expressed more Fas and Fas ligand (FasL) on their 
surface than cells from uninfected mice. To address the role of the death receptor, Fas, 
infection studies were performed with lpr mice that lack functional Fas expression. The 
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depletion of CD4+CD8+ thymocytes in lpr mice was comparable to that in C57BL/6 
mice indicating that it was independent of the Fas pathway. However, extensive loss of 
mitochondrial membrane potential was observed upon analysis with mitochondrial 
potential specific dyes MitoTracker Red and DiOC6. Most likely, the intrinsic death 
pathway involving mitochondrial depolarization is involved in this model of thymic 
atrophy. 
 
II. Since thymocytes are known to be sensitive to glucocorticoids both in vitro and in 
vivo, the involvement of the same in this model of thymic atrophy was assessed. The 
amounts of cortisol, a glucocorticoid, as detected by ELISA, were elevated during 
infection. To investigate the functional implication of the increase in cortisol, studies 
were performed using RU486, a glucocorticoid receptor antagonist. RU486 did not 
modulate cortisol amounts and treatment of mice with RU486 did not affect CFU 
burden or survival of mice. However there was a moderate rescue in the number of 
viable CD4+CD8+ thymocytes, with only a 3-4 fold drop as compared to the 8-10 fold 
drop in vehicle treated infected mice.  
 
III. As glucocorticoids appeared to play a partial role in this model, it was reasonable to 
assume that other pathways were also involved in the thymic atrophy. The quantitative 
and qualitative modulation of the cytokine milieu has a profound effect upon the 
thymus. In fact, inflammatory cytokines, Tnfα and Ifnγ, increased upon infection. In 
order to study the role of Ifnγ mediated inflammatory responses in this model, infection 
studies with Ifnγ-/- mice were performed. Ifnγ-/- mice had higher CFU and lower 
survival; however the drop in thymocyte numbers was 3-4 fold as compared to the 8-10 
fold drop in the infected C57BL/6 mice, again indicating a partial involvement of the 
Ifnγ mediated pathways.  
 
In order to study the interactions, if any, between the two pathways mentioned above, 
corticosteroid signaling was blocked in the Ifnγ-/- mice with RU486. Upon infection, the 
number of CD4+CD8+ thymocytes was significantly higher in Ifnγ-/- mice treated with 
RU486 (~1.5 fold drop in viable thymocyte numbers) along with lower caspase 3 
activity and mitochondrial damage. Importantly, cortisol amounts in infected Ifnγ-/- mice 
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were comparable to those in infected C57BL/6 mice and the administration of RU486 
did not modulate Tnfα and Ifnγ cytokine amounts in sera. Thus, the glucocorticoid and 
Ifnγ mediated pathways are parallel but synergize in an additive manner to induce death 
of CD4+CD8+ thymocytes during S. typhimurium infection.  
 
IV. Although thymic atrophy is known to occur, a detailed characterization of cell 
surface changes in thymocyte populations has not been performed. To investigate this 
aspect, thymocytes and MLN cells from uninfected and infected animals were stained 
for cell surface expression of CD3, CD4, CD5, CD8, CD24, CD25, CD44, CD69, MHC 
I and MHC II. This analysis was initially performed by studying the changes in 
expression of these molecules within the total thymocyte and MLN populations. 
Although there was no change in the expression of CD25 and MHC II in the total 
thymocyte population upon infection, CD24 expression reduced, whereas, the 
expression of CD3, CD5, CD44, CD69 and MHC I increased. Notably, changes in the 
frequency of expression of CD3, CD69 and MHC I were observed before the 
development of extensive thymic atrophy. The depletion of majority of the CD4+CD8+ 
thymocytes enriches the mature CD4+ or CD8+ thymocyte population This was 
corroborated with the observation that, upon in vitro stimulation with PMA and 
Ionomycin (pharmacological agents used to activate T cells) the residual thymocytes 
from infected mice produced more IL2 compared to thymocytes from uninfected mice.  
 
Subsequently, cells were stained with anti-CD4-FITC, anti-CD8-PE and a third 
biotinylated antibody, which was detected by a streptavidin-APC conjugate, against one 
of the remaining six markers. This three colour analysis made it possible to determine 
the changes in the expression of the third marker in each of the CD4-CD8-, CD4+CD8+, 
CD4+ and CD8+ populations upon infection. Distinct differences were observed in the 
phenotypes of uninfected and infected CD4+CD8+ thymocytes and the latter were 
CD3high, CD5high, CD24low, CD69high and MHC Ihigh indicating that the surviving 
population had a possibly more mature phenotype.  Also, the changes in the phenotypes 
of the thymocyte populations were dependent upon the extent of thymic atrophy as 
indicated by time course and CFU studies with C57BL/6 and BALB/c mice 
respectively.  Finally, the roles of glucocorticoids, Ifnγ and Nos2 in modulation of 
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expression of these markers during infection were addressed. Interestingly, the 
expression of CD3, CD24 and MHC class I significantly correlated with increase in the 
number of surviving thymocytes upon inhibition of glucocorticoids signaling and in 
Ifnγ-/- mice. The implications of these changes in the thymocyte surface phenotype 
during thymic atrophy are discussed.  
 
V. Finally, the roles of downstream signalling molecules in S. typhimurium induced 
thymic atrophy were studied. Although the MAP kinase family members, Erk, Jnk and 
p38 have been implicated to play a role in the positive and/or negative selection of 
thymocytes during development, their role in infection induced thymocyte depletion has 
not been studied. Interestingly, the amounts of Jnk and pJnk, but not p38, increased in 
thymocytes upon infection. Importantly, pJnk amounts increased predominantly in CD3-
/low thymocytes during infection. Furthermore, inhibition of Jnk signalling, using a 
specific inhibitor SP600125, lead to an increase in survival of CD4+CD8+ thymocytes 
during infection due to multiple reasons: lowering of cortisol, Tnfα and Ifnγ amounts, 
and better maintenance of thymic architecture. Thus, inhibition of Jnk mediated 
signaling protected CD4+CD8+ and CD3-/low thymocytes from death during S. 
typhimurium infection.  
 
Overall, the main conclusions of this study are as follows: First, extensive analysis of 
the surface phenotype of cells during thymic atrophy throws light on the sensitive and 
resistant thymocyte populations, thus offering a potential predictive marker profile. 
Second, glucocorticoids, Ifnγ and, importantly, Jnk mediated signaling play functional 
roles in the death of immature CD4+CD8+ thymocytes during S. typhimurium infection. 
The mechanistic details uncovered in this study may be important in designing effective 
strategies for reducing thymic atrophy during other infections. In fact, enhancement of 
thymic output may lead to greater numbers and diversity of thymic T cell emigrants in 
the periphery which is likely to enhance host responses during infections. 
